Effect of afatinib alone and in combination with dasatinib in triple-negative breast cancer cell lines.
Mohamed F.K. Ibrahim
No relevant relationships to disclose
Alexandra Canonici
Research Funding - Boehringer Ingelheim
Denis Collins
No relevant relationships to disclose
John Crown
Research Funding - Boehringer Ingelheim
Other Remuneration - Bristol-Myers Squibb
Norma O'Donovan
Research Funding - Boehringer Ingelheim